BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37243274)

  • 1. Transcription Factor Driven Gene Regulation in COVID-19 Patients.
    Santoni D; Ghosh N; Derelitto C; Saha I
    Viruses; 2023 May; 15(5):. PubMed ID: 37243274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
    Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
    Front Immunol; 2021; 12():789317. PubMed ID: 34975885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches.
    Hoque MN; Sarkar MMH; Khan MA; Hossain MA; Hasan MI; Rahman MH; Habib MA; Akter S; Banu TA; Goswami B; Jahan I; Nafisa T; Molla MMA; Soliman ME; Araf Y; Khan MS; Zheng C; Islam T
    Front Immunol; 2022; 13():918692. PubMed ID: 36059456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual.
    Yan B; Chakravorty S; Mirabelli C; Wang L; Trujillo-Ochoa JL; Chauss D; Kumar D; Lionakis MS; Olson MR; Wobus CE; Afzali B; Kazemian M
    J Virol; 2021 Jul; 95(15):e0029421. PubMed ID: 33980601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing.
    Mosharaf MP; Reza MS; Kibria MK; Ahmed FF; Kabir MH; Hasan S; Mollah MNH
    Sci Rep; 2022 Mar; 12(1):4279. PubMed ID: 35277538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements.
    Marston JL; Greenig M; Singh M; Bendall ML; Duarte RRR; Feschotte C; Iñiguez LP; Nixon DF
    JCI Insight; 2021 Dec; 6(24):. PubMed ID: 34731091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.
    Islam ABMMK; Khan MA; Ahmed R; Hossain MS; Kabir SMT; Islam MS; Siddiki AMAMZ
    J Transl Med; 2021 Jan; 19(1):32. PubMed ID: 33413422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new insight into sex-specific non-coding RNAs and networks in response to SARS-CoV-2.
    Askari N; Hadizadeh M; Rashidifar M
    Infect Genet Evol; 2022 Jan; 97():105195. PubMed ID: 34954105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Transcription Factors Regulating SARS-CoV-2 Tropism Factor Expression by Inferring Cell-Type-Specific Transcriptional Regulatory Networks in Human Lungs.
    Tong H; Chen H; Williams CM
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets.
    Li Y; Duche A; Sayer MR; Roosan D; Khalafalla FG; Ostrom RS; Totonchy J; Roosan MR
    BMC Genomics; 2021 Feb; 22(1):125. PubMed ID: 33602138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential core genes associated with COVID-19 identified via weighted gene co-expression network analysis.
    Wu C; Wu Z; Chen Y; Huang X; Tian B
    Swiss Med Wkly; 2022 Nov; 152():40033. PubMed ID: 36509426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis.
    Zhang C; Feng YG; Tam C; Wang N; Feng Y
    Front Immunol; 2021; 12():733171. PubMed ID: 34880855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.
    Marchi R; Sugita B; Centa A; Fonseca AS; Bortoletto S; Fiorentin K; Ferreira S; Cavalli LR
    Infect Genet Evol; 2021 Jul; 91():104832. PubMed ID: 33812037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
    Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
    EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 induces "cytokine storm" hyperinflammatory responses in RA patients through pyroptosis.
    Zheng Q; Lin R; Chen Y; Lv Q; Zhang J; Zhai J; Xu W; Wang W
    Front Immunol; 2022; 13():1058884. PubMed ID: 36532040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of transcriptomics data from COVID-19 patients: a pilot research.
    Hadzega D; Babisova K; Hyblova M; Janostiakova N; Sabaka P; Janega P; Minarik G
    Folia Microbiol (Praha); 2024 Feb; 69(1):155-164. PubMed ID: 38240884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease.
    Zhang W; Liu L; Xiao X; Zhou H; Peng Z; Wang W; Huang L; Xie Y; Xu H; Tao L; Nie W; Yuan X; Liu F; Yuan Q
    Front Immunol; 2023; 14():961642. PubMed ID: 37026010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Endogenous Retrovirus (HERV) Transcriptome Is Dynamically Modulated during SARS-CoV-2 Infection and Allows Discrimination of COVID-19 Clinical Stages.
    Grandi N; Erbì MC; Scognamiglio S; Tramontano E
    Microbiol Spectr; 2023 Feb; 11(1):e0251622. PubMed ID: 36602345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.